Showing 1 - 20 results of 24 for search 'Javier Fernández Ruiz', query time: 0.07s Refine Results
  1. 1
    The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy

    The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy by Santiago Rodríguez-Carreiro, Elisa Navarro, Eduardo Muñoz, Javier Fernández-Ruiz

    Published 2023-08-01
    Get full text
    Article
  2. 2
    New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia by Isabel Lastres-Becker, Eva de Lago, Ana Martínez, Javier Fernández-Ruiz

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease

    Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease by Sonia Burgaz, Concepción García, Maria Gómez-Cañas, Eduardo Muñoz, Javier Fernández-Ruiz

    Published 2019-07-01
    Get full text
    Article
  4. 4
    Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments

    Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments by Valentina Satta, Valentina Satta, Valentina Satta, Cristina Alonso, Cristina Alonso, Cristina Alonso, Paula Díez, Paula Díez, Paula Díez, Soraya Martín-Suárez, Marta Rubio, Juan M. Encinas, Juan M. Encinas, Juan M. Encinas, Javier Fernández-Ruiz, Javier Fernández-Ruiz, Javier Fernández-Ruiz, Onintza Sagredo, Onintza Sagredo, Onintza Sagredo

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

    Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease by Isabel Lastres-Becker, Francisco Molina-Holgado, José A. Ramos, Raphael Mechoulam, Javier Fernández-Ruiz

    Published 2005-06-01
    Get full text
    Article
  6. 6
    Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease

    Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease by Sonia Burgaz, Concepción García, María Gómez-Cañas, Alain Rolland, Eduardo Muñoz, Javier Fernández-Ruiz

    Published 2021-05-01
    Get full text
    Article
  7. 7
    Targeting cannabinoid CB2 receptors in the Central Nervous System. Medicinal chemistry approaches with focus on neurodegenerative disorders

    Targeting cannabinoid CB2 receptors in the Central Nervous System. Medicinal chemistry approaches with focus on neurodegenerative disorders by Gema Navarro, Paula Morales, Carmen Rodríguez-Cueto, Javier Fernández-Ruiz, Nadine Jagerovic, Rafael Franco

    Published 2016-09-01
    Get full text
    Article
  8. 8
    Pharmacokinetics of Sativex<sup>®</sup> in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

    Pharmacokinetics of Sativex<sup>®</sup> in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders by María Fernández-Trapero, Carmen Pérez-Díaz, Francisco Espejo-Porras, Eva de Lago, Javier Fernández-Ruiz

    Published 2020-02-01
    Get full text
    Article
  9. 9
    Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets

    Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Ta... by María Gómez-Ruiz, María Gómez-Ruiz, María Gómez-Ruiz, María Gómez-Ruiz, Carmen Rodríguez-Cueto, Carmen Rodríguez-Cueto, Carmen Rodríguez-Cueto, Eva Luna-Piñel, Eva Luna-Piñel, Eva Luna-Piñel, Eva Luna-Piñel, Mariluz Hernández-Gálvez, Mariluz Hernández-Gálvez, Mariluz Hernández-Gálvez, Mariluz Hernández-Gálvez, Javier Fernández-Ruiz, Javier Fernández-Ruiz, Javier Fernández-Ruiz

    Published 2019-04-01
    Get full text
    Article
  10. 10
    ANALYZING THE INFLUENCE OF CANNABIS SATIVA COMPOUNDS ON THE MYELINATION PROCESS IN A MURINE MODEL OF DRAVET SYNDROME

    ANALYZING THE INFLUENCE OF CANNABIS SATIVA COMPOUNDS ON THE MYELINATION PROCESS IN A MURINE MODEL OF DRAVET SYNDROME by Álvaro Sierra Tarazona, Valentina Satta, José Antonio Guimaré, Inés Hernández Fisac, Javier Fernández Ruiz, Onintza Sagredo

    Published 2023-10-01
    Get full text
    Article
  11. 11
    Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults.

    Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. by Marina Rubio, Hélène Villain, Fabian Docagne, Benoit D Roussel, José Antonio Ramos, Denis Vivien, Javier Fernandez-Ruiz, Carine Ali

    Published 2011-01-01
    Get full text
    Article
  12. 12
    EXPLORING THE MYELINATION STATUS IN A MURINE MODEL OF DRAVET SYNDROME

    EXPLORING THE MYELINATION STATUS IN A MURINE MODEL OF DRAVET SYNDROME by Valentina Satta, Álvaro Sierra Tarazona, José Antonio Guimaré Ortiz, Ines Hernández-Fisac, María Concepción García García, Javier Fernández Ruiz, Onintza Sagredo

    Published 2023-10-01
    Get full text
    Article
  13. 13
    Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis

    Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis by María Fernández-Trapero, Francisco Espejo-Porras, Carmen Rodríguez-Cueto, Joan R. Coates, Carmen Pérez-Díaz, Eva de Lago, Javier Fernández-Ruiz

    Published 2017-05-01
    Get full text
    Article
  14. 14
    THE EFFICACY OF COMBINED TREATMENT WITH ΒETA-CARYOPHYLLENE AND CANNABIDIOL IN A MOUSE MODEL OF DRAVET SYNDROME

    THE EFFICACY OF COMBINED TREATMENT WITH ΒETA-CARYOPHYLLENE AND CANNABIDIOL IN A MOUSE MODEL OF DRAVET SYNDROME by José Antonio Guimaré Ortiz, Valentina Satta, Álvaro Sierra Tarazona, Cristina Alonso Gómez, Ines Hernández-Fisac, Ana Gómez Soria, Onintza Sagredo, Javier Fernández Ruiz

    Published 2023-10-01
    Get full text
    Article
  15. 15
    Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice

    Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice by Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, Fabiana Piscitelli, Anna Lauritano, Che-Kun J. Shen, Vincenzo Di Marzo, Javier Fernández-Ruiz, Eva de Lago

    Published 2023-05-01
    Get full text
    Article
  16. 16
    BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis

    BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis by Marta Gómez-Almería, Sonia Burgaz, Carlos Costas-Insua, Carmen Rodríguez-Cueto, Irene Santos-García, Ignacio Rodríguez-Crespo, Concepción García, Manuel Guzmán, Eva de Lago, Javier Fernández-Ruiz

    Published 2021-11-01
    Get full text
    Article
  17. 17
    Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

    Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis by Ana Cabranes, Katerina Venderova, Eva de Lago, Filomena Fezza, Antonio Sánchez, Leyre Mestre, Marta Valenti, Antonio García-Merino, José Antonio Ramos, Vincenzo Di Marzo, Javier Fernández-Ruiz

    Published 2005-11-01
    Get full text
    Article
  18. 18
    Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

    Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice by Claudia Gonzalo-Consuegra, Irene Santos-García, Laura García-Toscano, Raquel Martín-Baquero, Carmen Rodríguez-Cueto, Matthias B. Wittwer, Pawel Dzygiel, Uwe Grether, Eva de Lago, Javier Fernández-Ruiz

    Published 2024-05-01
    Get full text
    Article
  19. 19
    Synthesis and pharmacological evaluation of new (E)- and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands

    Synthesis and pharmacological evaluation of new (E)- and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands by Vera L. M. Silva, Artur M. S. Silva, Diana C. G. A. Pinto, Patricia Rodríguez, Maria Gómez, Nadine Jagerovic, Luis F. Callado, José A. S. Cavaleiro, José Elguero, Javier Fernández-Ruiz

    Published 2010-08-01
    Get full text
    Article
  20. 20
    Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis

    Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis by Sonia Burgaz, Concepción García, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Francisco Ruiz-Pino, Juan Diego Unciti, María Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic, Carmen Rodríguez-Cueto, Eva de Lago, Eduardo Muñoz, Javier Fernández-Ruiz

    Published 2021-12-01
    Get full text
    Article

Search Tools: